Charter Communications Analyst Changes Stance; Check Out the Top 5 Downgrades for Monday
Analyst Downgrades: UBS analyst Kevin Caliendo downgraded Owens & Minor, Inc. from Buy to Neutral, lowering the price target from $7 to $4, with shares closing at $3.97.
Marsh & McLennan Companies: B of A Securities analyst Joshua Shanker downgraded Marsh & McLennan from Neutral to Underperform, reducing the price target from $243 to $181, as shares closed at $178.15.
Charter Communications: Keybanc analyst Brandon Nispel downgraded Charter Communications from Overweight to Sector Weight, with shares closing at $233.84.
Rigetti Computing and Canadian Solar: B. Riley Securities downgraded Rigetti Computing from Buy to Neutral, raising the price target from $35 to $42, while Jefferies downgraded Canadian Solar from Buy to Hold, increasing the price target from $13.7 to $19.64.
Trade with 70% Backtested Accuracy
Analyst Views on CHTR
About CHTR
About the author

- Position Change: Hussman Strategic Advisors disclosed in an SEC filing that it sold its entire position of 126,000 shares in TG Therapeutics, which previously represented 1.0% of its assets under management, indicating a cautious outlook on the company's future performance.
- Financial Performance: TG Therapeutics reported preliminary fourth-quarter revenue of $182 million for its main product as of January 30, and despite a significant 92.8% year-over-year growth to $161.7 million in the third quarter, the overall performance could not offset the 11.8% decline in its stock over the past year.
- Market Comparison: The underperformance of TG Therapeutics' stock, losing 11.8%, contrasts sharply with the Nasdaq Composite and S&P 500's gains of 20% and 15.8%, respectively, highlighting a lack of competitive edge in the biotechnology sector that may pose higher risks for investors.
- Investor Implications: The complete exit by Hussman suggests a diminishing confidence in TG Therapeutics, prompting investors to closely monitor the company's future strategic partnerships and clinical program developments to assess potential growth opportunities in oncology and immunology markets.
- High Valuations: Tesla and Palantir are currently trading at high price-to-earnings ratios, which may alienate value investors in the AI sector.
- Value AI Stocks: Despite the high valuations of some AI companies, there are still opportunities for value investors to find AI stocks that are more reasonably priced.
- Revenue Decline: Charter Communications reported a 2.3% year-over-year decline in Q4 revenue to $13.60 billion, missing the analyst consensus estimate of $13.74 billion, indicating increased market competition pressure on performance.
- Earnings Beat: Despite the revenue drop, Charter's EPS of $10.34 exceeded the analyst estimate of $9.90, demonstrating strong cost control and profitability amid challenging market conditions.
- Capex Adjustment: The company expects capital expenditures of approximately $11.4 billion for 2025, down from $11.7 billion, reflecting a cautious approach to future investments that may impact long-term growth potential.
- Stock Price Surge: Following the earnings announcement, Charter's stock price rose 4.5% to $215.45, indicating market confidence in the company's future growth strategy, despite differing analyst views on price targets.
- Analyst Rating Changes: Top Wall Street analysts have adjusted their ratings on several companies, indicating a shift in market sentiment that could influence investor decisions and market trends.
- AMZN Stock Outlook: Analysts' opinions on Amazon (AMZN) stock reveal a divergence in expectations for its future performance, prompting investors to pay attention to the latest ratings and price targets.
- Impact of Rating Changes: Upgrades and downgrades from analysts can lead to stock price volatility, necessitating that investors closely monitor these changes to adjust their investment strategies accordingly.
- Market Dynamics Observation: Changes in the overall market environment and economic data may also impact analysts' rating decisions, requiring investors to remain vigilant to address potential market risks.
- Stock Index Declines: The S&P 500 index fell by 0.43%, the Dow Jones Industrial Average dropped by 0.36%, and the Nasdaq 100 decreased by 1.28%, reflecting cautious investor sentiment following President Trump's nomination of Kevin Warsh as the new Fed Chair, which raised concerns about future monetary policy.
- Producer Prices Rise: The US December Producer Price Index (PPI) increased by 0.5% month-over-month and 3.0% year-over-year, both exceeding market expectations, indicating heightened inflationary pressures that could influence the Fed's policy decisions moving forward.
- Mining Stocks Plummet: Mining stocks faced significant sell-offs as gold and silver prices dropped sharply, with Coeur Mining and Hecla Mining declining over 17% and 15%, respectively, reflecting a pessimistic outlook on precious metals amid rising dollar strength.
- Positive Earnings Outlook: Despite the overall market decline, 102 S&P 500 companies are set to report earnings this week, with 77% of the 143 companies that have reported so far exceeding expectations, indicating resilience in corporate profitability, with S&P earnings growth projected to reach 8.4% in Q4.
U.S. Stock Market Performance: Stock indexes in the U.S. experienced a decline on Friday, with the overall market showing negative trends.
Specific Index Changes: The S&P 500 fell by 0.94%, the Dow Jones dropped by 0.43%, and the Nasdaq decreased by 0.36%.











